These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10849568)

  • 1. Yohimbine in erectile dysfunction: the facts.
    Morales A
    Int J Impot Res; 2000 Mar; 12(S1):S70-S74. PubMed ID: 10849568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yohimbine in erectile dysfunction: the facts.
    Morales A
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S70-74. PubMed ID: 10845767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed?
    Morales A
    World J Urol; 2001 Aug; 19(4):251-5. PubMed ID: 11550783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12(S1):S75-S80. PubMed ID: 10849569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II.
    Moyad MA; Barada JH; Lue TF; Mulhall JP; Goldstein I; Fawzy A;
    Urol Clin North Am; 2004 May; 31(2):259-73. PubMed ID: 15123406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yohimbine in the treatment of erectile disorder.
    Riley AJ
    Br J Clin Pract; 1994; 48(3):133-6. PubMed ID: 8031688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial.
    Guay AT; Spark RF; Jacobson J; Murray FT; Geisser ME
    Int J Impot Res; 2002 Feb; 14(1):25-31. PubMed ID: 11896474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system agents in the treatment of erectile dysfunction.
    Kendirci M; Walls MM; Hellstrom WJ
    Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New directions for erectile dysfunction therapies.
    Andersson KE; Hedlund P
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S82-92. PubMed ID: 11850740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.